Pharmaceutical supply chains are not in the business of delivering products. They are responsible for human wellbeing and delivering high-quality care to patients. For that reason, there’s nothing more important than reliability in pharma & healthcare logistics. In the current situation, the flexibility to respond to the reality of the task at hand is also paramount. For instance, a company may meet critical deadlines by flying its Covid-19 vaccine to those hit by another wave of the pandemic. Conversely, for the planned global rollout of billions of doses of the vaccine, the same company may want to ship its product across continents.

The question is, are today’s carriers equipped to transport the most fragile, high-value, regulated cargo in the world?

Re-evaluating the modal mix for pharmaceutical supply chains

The evolution of Ocean logistics for Pharmaceuticals

Transporting high-value cargo over long distances with zero room for error is a complex affair, only to be made more challenging by the multiple audits imposed by Pharma companies and regulators.

Over the years, however, supply chain solution providers have taken a strategic approach to minimise logistics risks on the ocean. At the heart of this approach is a commitment to complete supply chain transparency using integrated digital platforms and visibility tools. With such solutions, logistics service providers are now able to put control back into the hands of Pharma businesses by enabling them to take real-time decisions that prevent issues and minimise the loss of their sensitive cargo.

More recently, the industry has identified the need for new inventory models that shock-proof their businesses. Here too, Ocean solutions play the role of a ‘floating warehouse’, enabling manufacturers to supplement their just-in-time with just-in-case (safety stock) inventory strategies.

But is this enough for Pharma companies to substantially increase Ocean’s share in their modal mix?

Ocean transportation is reliable

Historically, companies have tried to overcome the complexities of running a Pharma supply chain with speed – the faster you take a product from A to B, the fewer errors you’re likely to experience along the way, right? Unfortunately, this isn’t always the case. Pallets are vulnerable to temperature deviations and contamination on the tarmac, especially if there are multiple handoffs and handling of the product.

Refrigerated containers, on the other hand, can take a Pharma product from production to patient with minimal handling, as the door of the container need not be opened at all. Remote container visibility and monitoring help Pharma manufacturers stay ahead of possible issues. And proactive issue handling prevents temperature deviations from resulting in loss of the product. It should come as no surprise then that ocean-related excursions amount to less than 1% of all excursions in one journey.

Ocean logistics can make products accessible to everyone

Today, 30-40% of the cost of a vaccine can be attributed to its transportation. Yet, the need to keep quality, care and service levels high has always put the reduction of logistics costs on the back seat.

Not anymore.

Companies aiming to make the Covid-19 vaccine accessible to middle and low-income families around the world are now looking for ways to keep their vaccine affordable. Ocean transport makes this possible as it is approximately 78% less expensive than Air transport.

Ocean solutions are sustainable

Air transport emits 1,000 gm of CO2 per kg of products per 1,000km. In comparison, Ocean transport emits only 40 gm of CO2 per kg of products per 1,000km. That means increasing the role of Ocean in your modal mix can reduce your carbon footprint by up to 1/25 times per journey, improving brand reputation a great deal.

Making Ocean a viable option for Pharma companies

International Pharma companies approach Maersk because of our extensive network, our 80+ years of experience in refrigerated cargo transportation, and our fleet of 360,000 containers (the largest in the world). They sign up with us because they believe our Reefer excellence team and our end to end portfolio of logistics solutions — including Air Freight, Inland, Warehousing and Distribution, and real-time data solutions — can simplify and connect their supply chains. They remain partners with us because we go all the way to protect the integrity of their products by improving infrastructure at terminals, ensuring faster handovers, planning last-mile flows more efficiently, and providing complete transparency throughout the cold chain.

Don’t take our word for it.

If you’re looking to ship your Pharma products, you can reach out to us to discuss a trial. If our quality approach and operational efficiency meet your needs, we can join hands as partners.

Hristo Petkov
Hristo Petkov
Global Head of Pharma & Healthcare Vertical

Anything you need, we’re here to help

솔루션

솔루션

공급망의 시작부터 끝까지 고객의 요구를 충족하기 위해 최선을 다합니다.
문의하기

문의하기

전문가로 이루어진 전담팀이 고객분들을 위해 대기하고 있습니다.
운임 찾기

화물을 운송할 준비가 되셨나요?

새로운 해상 운송 및 내륙 운송 요율을 찾습니다.
소식 받기
뉴스와 인사이트 구독
최신 공급망 트렌드를 이메일로 받아보세요

이 양식을 제출하면 A. P. Moller-Maersk 및 그 계열사로부터 이메일을 통해 물류 관련 뉴스 및 마케팅 소식을 수신하는 데 동의합니다 . 본인은 구독 취소 링크를 클릭하면 언제든지 Maersk 마케팅을 수신 거부할 수 있습니다. 개인 정보를 처리하는 방법에 대한 자세한 내용은 개인정보 고지를 참조하세요.

등록해 주셔서 감사합니다
뉴스레터를 구독하셨습니다. 뉴스레터 기본 설정 방법이 담긴 이메일을 곧 보내드립니다.
구독 중
언제든지 구독을 취소할 수 있습니다.